High dose interferon treatment in chronic hepatitis C.
Author:
Abstract
One hundred and twenty six patients were enrolled in a study to assess the effect of different interferon alfa-2b treatment regimens on the rate of increase in alanine aminotransferase (ALT) activities after treatment. Results indicated that a high daily dosage of interferon (10 million units (MU)) given six times a week for two weeks followed by 12 weeks of thrice weekly dosing was more effective at producing sustained normal ALT values than either eight weeks of 10 MU interferon six times a week or four weeks of 10 MU six times a week followed by eight weeks of thrice weekly dosing. Multiple regression analysis of clinical parameters before treatment showed that the outcome was dependent upon treatment group (p < 0.001) and the initial hepatitis C virus (HCV)-RNA value (p < 0.05). Anti-HCV titre and liver histology had a considerable but not significant effect on the response to treatment. The most frequently observed side effect was flu like syndrome, which occurred in over 90% of patients. In addition, 21% of patients experienced some degree of hair loss. Treatment was stopped because of side effects in 11 of 126 (9%) patients, evenly distributed between the three groups.Keywords
This publication has 10 references indexed in Scilit:
- Interferon for non-A, non-B chronic hepatitisJournal of Hepatology, 1991
- Interferon-induced chronic active hepatitis?Gastroenterology, 1991
- Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.1991
- Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assayThe Lancet, 1991
- DETECTION OF HEPATITIS-C VIRUS-RNA BY A 2-STAGE POLYMERASE CHAIN-REACTION WITH 2 PAIRS OF PRIMERS DEDUCED FROM THE 5'-NONCODING REGION1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- CLINICAL SIGNIFICANCE OF ANTI-IFN-α ANTIBODY TITRES DURING INTERFERON THERAPYThe Lancet, 1987
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Thyroid Autoimmunity in Patients on Long Term Therapy with Leukocyte-Derived Interferon*The Journal of Clinical Endocrinology & Metabolism, 1986